Potential therapeutic effects of ethyl pyruvate in an experimental rat appendicitis model
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Nov 2021 · 1 min read
In brief
In brief
Experimental study demonstrates that ethyl pyruvate combined with ceftriaxone significantly reduces inflammation, adhesions, and IL-6 levels in rat appendicitis compared to antibiotic monotherapy. Findings suggest EP's antioxidant properties may enhance standard treatment efficacy, warranting clinical translation studies.
Written by the GCMD Library team from the article.
Background
Pathophysiology of appendicitis is associated with the underlying inflammatory processes. Ethyl pyruvate (EP) has potent antioxidant and anti-inflammatory properties. In this study, we aimed to investigate the effects of EP on the treatment of appendicitis and to examine whether adding EP to the antibiotic treatment could increases the effectiveness of the treatment in a rat appendicitis model.
Method
Thirty two Wistar rats, which had previously created appendicitis, were randomly divided into 4 groups: Group 1 (0.1 ml saline solution), Group 2 (15 mg/kg ceftriaxone), Group 3 (50 mg/kg EP), Group 4 (EP 50 mg/kg + ceftriaxone 15 mg/kg). In all groups, saline solution, ceftriaxone and EP were administered intraperitoneally and the same procedure was repeated twice a day for the following five days. On day 6, the rats underwent relaparotomy and then intraabdominal findings were recorded. Histopathological examination and interleukin-6 (IL-6) level were performed on appendiceal specimens.
Results
Intra-abdominal adhesion score was significantly lower in Group 4 than in Group 1. Total inflammation score was significantly lower in Group 2 than in Group 1 and was significantly lower in Group 4 than in Group 3 and 1. IL-6 level was significantly lower in Group 4 than in Group 3 and 1.
Conclusion
We found that adding EP to the antibiotic therapy increased the efficacy of the treatment in the rat appendicitis model. Further studies are required to apply our findings to the clinical setting.